NICE has published a Medtech Innovation Briefing recognising that Adherium’s Smartinhaler technology is more effective in improving adherence to asthma medication than current NHS practice.
Internis Pharma Binosto is now widely available across the UK, offering patients with osteoporosis the chance to access the first buffered formulation of alendronate designed to minimise gastrointestinal side effects commonly linked with traditional versions of the drug.